PMC:7696151 / 57382-57536 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1677","span":{"begin":34,"end":37},"obj":"Chemical"},{"id":"1689","span":{"begin":45,"end":61},"obj":"Disease"}],"attributes":[{"id":"A1677","pred":"tao:has_database_id","subj":"1677","obj":"MESH:D006886"},{"id":"A1689","pred":"tao:has_database_id","subj":"1689","obj":"MESH:D012859"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Even if preliminary results about HCQ use in Sjögren syndrome were not encouraging, to date it arises as one of the first-line drugs in disease treatment."}

{"project":"LitCovid-sentences","denotations":[{"id":"T370","span":{"begin":0,"end":154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Even if preliminary results about HCQ use in Sjögren syndrome were not encouraging, to date it arises as one of the first-line drugs in disease treatment."}